- ACRS -5.93%
Earnings Update: Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Just Reported And Analysts Are Boosting Their Estimates
Yahoo Finance · 2 weeks ago
Open | 1.1800 |
High | 1.1800 |
Low | 1.1100 |
Mkt Cap | 79.1M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 1.1800 |
52 Wk. Low | 0.5900 |
52 Wk. High | 11.1200 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 2.4M | 5.10% ▼ |
Net Income | -16.94M | - |
Diluted EPS | -0.24 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.20 | - |
Q1 2024 | -$0.29 | -$0.24 |
Q4 2023 | -$0.34 | -$0.02 |
S&P 500^GSPC | 5,304.72+36.88 (+0.70%) |
Dow 30^DJI | 39,069.59+4.33 (+0.01%) |
Nasdaq^IXIC | 16,920.79+184.76 (+1.10%) |
0.9830+428.49% | |
809.73+1.68% | |
Workday, Inc.WDAY | 220.91-15.33% |